[1]
P. Chaiyarat, S. Manachevakul, and S. Phopongsin, “Targeted Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comparison of Erlotinib and Osimertinib within the Thai Healthcare System”, J.HPLA, vol. 12, no. 2, pp. 383–394, Apr. 2026.